- Home
- EVC vs ACHV Comparison
EVC vs ACHV Comparison
Compare EVC & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- ACHV
- Stock Information
- Founded
- EVC 1996
- ACHV N/A
- Country
- EVC United States
- ACHV United States
- Employees
- EVC N/A
- ACHV N/A
- Industry
- EVC Broadcasting
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EVC Industrials
- ACHV Health Care
- Exchange
- EVC Nasdaq
- ACHV Nasdaq
- Market Cap
- EVC 188.3M
- ACHV 72.5M
- IPO Year
- EVC 2000
- ACHV N/A
- Fundamental
- Price
- EVC $2.43
- ACHV $2.07
- Analyst Decision
- EVC
- ACHV Strong Buy
- Analyst Count
- EVC 0
- ACHV 3
- Target Price
- EVC N/A
- ACHV $14.33
- AVG Volume (30 Days)
- EVC 361.7K
- ACHV 1.2M
- Earning Date
- EVC 08-07-2025
- ACHV 08-12-2025
- Dividend Yield
- EVC 8.32%
- ACHV N/A
- EPS Growth
- EVC N/A
- ACHV N/A
- EPS
- EVC N/A
- ACHV N/A
- Revenue
- EVC $378,623,000.00
- ACHV N/A
- Revenue This Year
- EVC $64.06
- ACHV N/A
- Revenue Next Year
- EVC N/A
- ACHV N/A
- P/E Ratio
- EVC N/A
- ACHV N/A
- Revenue Growth
- EVC 23.10
- ACHV N/A
- 52 Week Low
- EVC $1.58
- ACHV $1.84
- 52 Week High
- EVC $2.73
- ACHV $5.31
- Technical
- Relative Strength Index (RSI)
- EVC 62.30
- ACHV 32.75
- Support Level
- EVC $2.19
- ACHV $2.00
- Resistance Level
- EVC $2.46
- ACHV $3.90
- Average True Range (ATR)
- EVC 0.11
- ACHV 0.27
- MACD
- EVC 0.01
- ACHV -0.18
- Stochastic Oscillator
- EVC 90.91
- ACHV 3.68
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.